News Focus
News Focus
Followers 65
Posts 10174
Boards Moderated 0
Alias Born 03/29/2015

Re: FeMike post# 737038

Thursday, 12/12/2024 11:24:34 AM

Thursday, December 12, 2024 11:24:34 AM

Post# of 819929

Look at the latest Q for evidence that they have a slew of good news they could PR but are choosing not to. Combo deals. Direct restart. RP trial expansions. etc.

I don't agree with that strategy. I think it is selfish, ignorant, short sighted or sleazy of LP to continue diluting at these prices while sitting on good news; but, that is their strategy nonetheless.



PRing is not enough if that is far as they are willing to exert themselves because the market has a ‘show me’ attitude with NWBO.

In other words, most of those good news items are not necessarily worth PRing so long as NWBO proves unwilling to engage more closely with the media and attend investor (not just scientific) conferences etc.

We know this from hard experience with supposed binary events / supposedly huge catalysts that fell flat because of the desultory way they were handled on the PR side by the company or who they outsourced the presentation to.

So if big news items have had next to no impact when poorly released using NWBO’s chosen PR strategy then how much less would dribs and drabs of smaller news do for us?

It is December 2024 and the DC-Vac-L trial started longer ago than some adults have been alive.

Many who invested in NWBO as young men and women are now middle-aged and many who invested in middle-age are now elderly and looking to their heirs to realize the benefit.

In this context, the market could care less about small PR potatoes from a company with an history of false dawns.

What I pray they’ve been doing during this extremely long wait is figure out how to make MHRA approval resound in the media and generate a huge return for shareholders (as measured by the SP). We have waited long enough, whether it is 5 years or 10 years or 15 years.

I emotionally resisted for NWBO to whiff on getting a truly huge (and permanent) SP increase with MHRA approval. As annoying as it will be I am ready for the usual voices to gaslight us and just move the goal posts to FDA approval. As always I truly desire for this time to finally, finally, be different.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News